News   /   Economy

Iran self-sufficient in making active ingredient of acetaminophen

Iran announces self-sufficiency in making the active ingredient needed to manufacture acetaminophen.

Iran has announced self-sufficiency in making the active ingredient needed to manufacture acetaminophen drugs amid efforts in the country cut back reliance on foreigners for medical supplies.  

Deputy head of Iran’s syndicate of active pharmaceutical ingredients said on Tuesday that researchers in the country had managed to launch domestic production of para-aminophenol which is the active ingredient needed to make acetaminophen drugs.

Mohammad Reza Mousavi said Iran used to rely on China and India for imports of para-aminophenol supplies.

“Fortunately, we are producing this ingredient inside the country thanks to efforts by Iranian researchers and knowledge-based firms and the support provided by (Iran’s) Food and Drug Administration,” said Mousavi.

He added that para-aminophenol is being manufactured in a pharmaceutical company in Shazand in the central Markazi province, adding that the project has cost some $10 million and more than 30 months of research work.

Mousavi said acetaminophen drugs produced in Iran are currently supplied in large quantities to the markets in neighboring Iraq where they are either re-exported to other markets or used inside the Arab country.

He said Iran will soon become self-sufficient in manufacturing active ingredients needed in making drugs like aspirin and metformin.


Press TV’s website can also be accessed at the following alternate addresses:

www.presstv.co.uk

SHARE THIS ARTICLE
Press TV News Roku